Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

Full Title

Pragmatic Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) (AI)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Veronica Rotemberg’s office at 646-608-2341. 

Protocol
26-209
Phase
Phase III (phase 3)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT07890415